Skip to Content
Commentary

The Week Ahead: Earnings From Johnson & Johnson, Verizon, JPMorgan

The new earnings season kicks off with names from a variety of sectors.

Mentioned: , , , , , , , , ,

We are gearing up as third-quarter earnings season comes into full swing. 

The week begins with earnings announcements from United Airlines (UAL) and Charles Schwab (SCHW) on Monday. On Tuesday, healthcare giant Johnson & Johnson (JNJ) will report. Our analyst expects the $8 billion ruling against Johnson & Johnson regarding side effects to neuroscience Risperdal to fall significantly on appeal. Analysts do not believe that the overall legal challenge poses a major threat to Johnson & Johnson’s Morningstar Economic Moat Rating of wide.

To view this article, become a Morningstar Basic member.

Register for Free

Jess Liu does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.